When it comes to investing in pharmaceutical companies, looking at pipelines and research and development prospects is important. But in-licensing is also key when examining these stocks. In fact, ...

An update from Conduit Pharmaceuticals ( ($CDT) ) is now available. On December 28 and 29, 2025, CDT Equity Inc. entered into consulting ...

On 22 February 2024, shortly before the second anniversary of Russia’s invasion of Ukraine, the UK government published its first sanctions strategy (the Strategy). 1 The Strategy explains the UK’s ...

Regulatory execution is emerging as one of the most important gating factors for commercializing advanced nuclear technologies, where licensing timelines often determine whether projects advance or ...

The life sciences industry has long been at the forefront of innovation, and 2025 promises to continue this trajectory with exciting developments in intellectual property (IP), licensing, and mergers ...

The new strategy and structure is a key part of Aardman’s Brand and Licensing division’s plans to maximise the impact and value of the studio’s IP around the world. Aardman has announced a new ...

QuantumScape's pivot to a capital-light licensing model with Volkswagen's PowerCo extends its cash runway to 2028, mitigating balance sheet stress. The company is progressing with its Raptor and Cobra ...

CEO Patrizio Vinciarelli highlighted a transformative quarter for Vicor, stating the company recorded product revenues and licensing income of $110.4 million, with Advanced Products revenue at $65.5 ...

In a world where innovation is no longer an option but a necessity, the technology licensing business model stands at the forefront of a new wave of growth across key sectors such as automotive, ...